Dr. Reddy’s Laboratories Investor Relations Material
Latest events
Q3 23/24
Dr. Reddy’s Laboratories
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Dr. Reddy’s Laboratories Limited
Access all reports
Segment Data
Access more data
Revenue by
Business area
Global Generics
PSAI
Proprietary products
Other
Expenses by
Financials
Dr. Reddy’s Laboratories, an integrated pharmaceutical company worldwide, discovers, develops, manufactures and markets innovative branded generic pharmaceuticals and formulations in specialty areas primarily neurology and psychiatry. The company also markets and distributes products, including pharmaceutical intermediates and active pharmaceutical ingredients (APIs); animal health-related products; nutraceuticals/food supplements; and chemicals. The company offers a range of products comprising of tablets, capsules, fine granules, liquids and injectable pharmaceuticals, transdermal patches, ointments, creams, sprays and others. It markets its products through wholesalers and distributors to pharmacies, pharmacists and hospitals; chain drug stores; mass market retailers; e-commerce websites; government institutions; missionary organizations; etc.
Key slides for Dr. Reddy’s Laboratories Limited
Q1 23/24
Dr. Reddy’s Laboratories Limited
Q1 23/24
Dr. Reddy’s Laboratories Limited
Latest articles
Sundar Pichai: CEO of Alphabet and Google
Explore Sundar Pichai's improbable journey from Chennai, India, to becoming one of the most powerful individuals on the planet.
19 Apr 2024
The Three Cornerstones of Serial Acquirer Success
Explore what is behind successful serial acquirers: efficient capital use, decentralization, and a strong focus on people.
19 Apr 2024
Companies That Had Their IPO in 2023: Cautious Optimism
The cautiously optimistic market in 2023 saw stocks rebounded upwards, and interest in IPOs picked up from the previous year.
15 Apr 2024
Ticker symbol
Country
🇮🇳 India